Shape and size-dependent immune response to antigen-carrying nanoparticles

Journal of Controlled Release

Volumn 220, Issue , 2015, Pages 141-148

  Kumar, Sunny ^a   Anselmo, Aaron C ^a   Banerjee, Amrita ^a   Zakrewsky, Michael ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Antigen; Immune response; Morphology; Nanoparticles; Shape; Size; Vaccine

Indexed keywords

ANTIGENS; CELLS; KNOWLEDGE MANAGEMENT; MORPHOLOGY; NANOPARTICLES; SPHERES; VACCINES;

ANTIGEN PRESENTATION; IMMUNE RESPONSE; MORPHOLOGICAL FEATURES; POLYSTYRENE PARTICLE; ROD-SHAPED PARTICLES; SHAPE; SIZE; SPHERICAL PARTICLE;

IMMUNE SYSTEM;

ANTIGEN; NANOPARTICLE; OVALBUMIN; POLYSTYRENE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONJUGATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; IMMUNOLOGY; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN; PARTICLE SIZE; TH1 CELLS; TH2 CELLS;

EID: 84945917314     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.069     Document Type: Article

References (56)

1. M.F. Bachmann, and G.T. Jennings Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns Nat. Rev. Immunol. 10 2010 787 796
2. P. Sahdev, L.J. Ochyl, and J.J. Moon Biomaterials for nanoparticle vaccine delivery systems Pharm. Res. 31 2014 2563 2582
3. S.L. Demento, A.L. Siefert, A. Bandyopadhyay, F.A. Sharp, and T.M. Fahmy Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines Trends Biotechnol. 29 2011 294 306
4. P. Elamanchili, C.M. Lutsiak, S. Hamdy, M. Diwan, and J. Samuel Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells J. Immunother. 30 2007 378 395
5. S.T. Reddy, A. Rehor, H.G. Schmoekel, J.A. Hubbell, and M.A. Swartz In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles J. Control. Release 112 2006 26 34
6. S. Kumar, and H. Tummala Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system Mol. Pharm. 10 2013 1845 1853
7. A.C. Rice-Ficht, A.M. Arenas-Gamboa, M.M. Kahl-McDonagh, and T.A. Ficht Polymeric particles in vaccine delivery Curr. Opin. Microbiol. 13 2010 106 112
8. C. Thomasin, G. Corradin, Y. Men, H.P. Merkle, and B. Gander Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response J. Control. Release 41 1996 131 145
9. S.K. Mallapragada, and B. Narasimhan Immunomodulatory biomaterials Int. J. Pharm. 364 2008 265 271
10. M.O. Oyewumi, A. Kumar, and Z. Cui Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses Expert Rev. Vaccines 9 2010 1095 1107
11. K. Niikura, T. Matsunaga, T. Suzuki, S. Kobayashi, H. Yamaguchi, Y. Orba, A. Kawaguchi, H. Hasegawa, K. Kajino, and T. Ninomiya Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo ACS Nano 7 2013 3926 3938
12. C. Foged, B. Brodin, S. Frokjaer, and A. Sundblad Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model Int. J. Pharm. 298 2005 315 322
13. J.M.M. Gómez, N. Csaba, S. Fischer, A. Sichelstiel, T.M. Kündig, B. Gander, and P. Johansen Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis J. Control. Release 130 2008 161 167
14. S.-Y. Seong, and P. Matzinger Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses Nat. Rev. Immunol. 4 2004 469 478
15. D.F. Moyano, M. Goldsmith, D.J. Solfiell, D. Landesman-Milo, O.R. Miranda, D. Peer, and V.M. Rotello Nanoparticle hydrophobicity dictates immune response J. Am. Chem. Soc. 134 2012 3965 3967
16. Y.K. Katare, T. Muthukumaran, and A.K. Panda Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles Int. J. Pharm. 301 2005 149 160
17. I. Gutierro, R. Hernandez, M. Igartua, A. Gascon, and J. Pedraz Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
18. T. Jung, W. Kamm, A. Breitenbach, K.-D. Hungerer, E. Hundt, and T. Kissel Tetanus toxoid loaded nanoparticles from sulfobutylated poly (vinyl alcohol)-graft-poly (lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice Pharm. Res. 18 2001 352 360
19. J. Wendorf, J. Chesko, J. Kazzaz, M. Ugozzoli, M. Vajdy, D. O'Hagan, and M. Singh A comparison of anionic nanoparticles and microparticles as vaccine delivery systems Hum. Vaccin. 4 2008 44 49
20. V. Kanchan, and A.K. Panda Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response Biomaterials 28 2007 5344 5357
21. Y. Liu, Y. Yin, L. Wang, W. Zhang, X. Chen, X. Yang, J. Xu, and G. Ma Surface hydrophobicity of microparticles modulates adjuvanticity J. Mater. Chem. B 1 2013 3888 3896
22. G. Sharma, D.T. Valenta, Y. Altman, S. Harvey, H. Xie, S. Mitragotri, and J.W. Smith Polymer particle shape independently influences binding and internalization by macrophages J. Control. Release 147 2010 408 412
23. Y. Tabata, and Y. Ikada Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage Biomaterials 9 1988 356 362
24. S.D. Xiang, A. Scholzen, G. Minigo, C. David, V. Apostolopoulos, P.L. Mottram, and M. Plebanski Pathogen recognition and development of particulate vaccines: does size matter? Methods 40 2006 1 9
25. N. Doshi, and S. Mitragotri Macrophages recognize size and shape of their targets PLoS One 5 2010 e10051
26. S. Mitragotri In drug delivery, shape does matter Pharm. Res. 26 2009 232 234
27. J.A. Champion, and S. Mitragotri Shape induced inhibition of phagocytosis of polymer particles Pharm. Res. 26 2009 244 249
28. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J. Control. Release 121 2007 3 9
29. S.M. Moghimi, A.J. Andersen, D. Ahmadvand, P.P. Wibroe, T.L. Andresen, and A.C. Hunter Material properties in complement activation Adv. Drug Deliv. Rev. 63 2011 1000 1007
30. C. Salvador-Morales, E. Flahaut, E. Sim, J. Sloan, M.L. Green, and R.B. Sim Complement activation and protein adsorption by carbon nanotubes Mol. Immunol. 43 2006 193 201
31. W.L. Ling, A. Biro, I. Bally, P. Tacnet, A. Deniaud, E. Doris, P. Frachet, G. Schoehn, E. Pebay-Peyroula, and G.J. Arlaud Proteins of the innate immune system crystallize on carbon nanotubes but are not activated ACS Nano 5 2011 730 737
32. A.C. Anselmo, J.B. Gilbert, S. Kumar, V. Gupta, R.E. Cohen, M.F. Rubner, and S. Mitragotri Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation J. Control. Release 199 2015 29 36
33. J.A. Champion, and S. Mitragotri Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 103 2006 4930 4934
34. P. Sahdev, S. Podaralla, R.S. Kaushik, and O. Perumal Calcium phosphate nanoparticles for transcutaneous vaccine delivery J. Biomed. Nanotechnol. 9 2013 132 141
35. Z. Shen, G. Reznikoff, G. Dranoff, and K.L. Rock Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J. Immunol. 158 1997 2723 2730
36. J.A. Champion, Y.K. Katare, and S. Mitragotri Making polymeric micro- and nanoparticles of complex shapes Proc. Natl. Acad. Sci. 104 2007 11901 11904
37. P. Kolhar, A.C. Anselmo, V. Gupta, K. Pant, B. Prabhakarpandian, E. Ruoslahti, and S. Mitragotri Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium Proc. Natl. Acad. Sci. 110 2013 10753 10758
38. H. Li, S.B. Willingham, J.P.-Y. Ting, and F. Re Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3 J. Immunol. 181 2008 17 21
39. E.B. Lindblad Aluminium compounds for use in vaccines Immunol. Cell Biol. 82 2004 497 505
40. P. Marrack, A.S. McKee, and M.W. Munks Towards an understanding of the adjuvant action of aluminium Nat. Rev. Immunol. 9 2009 287 293
41. J.M. Blander, and L.E. Sander Beyond pattern recognition: five immune checkpoints for scaling the microbial threat Nat. Rev. Immunol. 12 2012 215 225
42. D.J. Irvine, M.C. Hanson, K. Rakhra, and T. Tokatlian Synthetic nanoparticles for vaccines and immunotherapy Chem. Rev. 2015 10.1021/acs.chemrev.5b00109
43. C. Thomas, V. Gupta, and F. Ahsan Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles Pharm. Res. 27 2010 905 919
44. J.A. Champion, A. Walker, and S. Mitragotri Role of particle size in phagocytosis of polymeric microspheres Pharm. Res. 25 2008 1815 1821
45. N. Doshi, A.J. Swiston, J.B. Gilbert, M.L. Alcaraz, R.E. Cohen, M.F. Rubner, and S. Mitragotri Cell-based drug delivery devices using phagocytosis-resistant backpacks Adv. Mater. 23 2011 H105 H109
46. R. Agarwal, V. Singh, P. Jurney, L. Shi, S.V. Sreenivasan, and K. Roy Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms Proc. Natl. Acad. Sci. U. S. A. 110 2013 17247 17252
47. V. Manolova, A. Flace, M. Bauer, K. Schwarz, P. Saudan, and M.F. Bachmann Nanoparticles target distinct dendritic cell populations according to their size Eur. J. Immunol. 38 2008 1404 1413
48. A.C. Anselmo, M. Zhang, S. Kumar, D.R. Vogus, S. Menegatti, M.E. Helgeson, and S. Mitragotri Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting ACS Nano 9 2015 3169 3177
49. C.A. Fromen, G.R. Robbins, T.W. Shen, M.P. Kai, J.P. Ting, and J.M. DeSimone Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization Proc. Natl. Acad. Sci. 112 2015 488 493
50. C.V. Harding, and R. Song Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules J. Immunol. 153 1994 4925 4933
51. A. Rodriguez, A. Regnault, M. Kleijmeer, P. Ricciardi-Castagnoli, and S. Amigorena Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells Nat. Cell Biol. 1 1999 362 368
52. B. Sun, Z. Ji, Y.P. Liao, M. Wang, X. Wang, J. Dong, C.H. Chang, R. Li, H. Zhang, A.E. Nel, and T. Xia Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles ACS Nano 7 2013 10834 10849
53. Z. Ji, X. Wang, H. Zhang, S. Lin, H. Meng, B. Sun, S. George, T. Xia, A.E. Nel, and J.I. Zink Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials ACS Nano 6 2012 5366 5380
54. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, and J.A. Hubbell Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat. Biotechnol. 25 2007 1159 1164
55. M.A. Swartz, J.A. Hubbell, and S.T. Reddy Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design Semin. Immunol. 20 2008 147 156
56. J.C. Sunshine, K. Perica, J.P. Schneck, and J.J. Green Particle shape dependence of CD8 + T cell activation by artificial antigen presenting cells Biomaterials 35 2014 269 277